
De Rigo acquires Rodenstock eyewear
Italian-based, family-owned De Rigo Vision has acquired Rodenstock’s eyewear division, adding two prestigious brands to its portfolio while strengthening its distribution platform and regional
4295 articles

Italian-based, family-owned De Rigo Vision has acquired Rodenstock’s eyewear division, adding two prestigious brands to its portfolio while strengthening its distribution platform and regional

Eyewear company Oscar Wylee New Zealand is providing free eye tests for kids aged 5-17 years. The initiative was developed to encourage kids and parents in the community to take care of their eye

EssilorLuxottica Australia New Zealand has launched Essilor Stellest lenses, designed to correct vision and slow myopia progression.

A large UK study found poor quality sleep was associated with increased glaucoma risk.

Directly from Silmo Paris 2022’s Trends Forum, Vanni’s new Dama line, made with the company’s exclusive acetate, captures reflections and transforms them into shimmering movement on the frames’ surface. The name was inspired by the material’s resemblance to the pearlescent sheen of damask fabrics, s

Dispensing optician Pene Fox has launched Bespectacled Optical Dispensary.

Israel’s Azura Ophthalmics announced positive three-month efficacy and safety results from its phase 2b study on its keratolytic eye preparation AZR-MD-001 0.5% in meibomian gland dysfunction (MGD).

Designed by New Zealand optometrist and entrepreneur Paul Rose for post-surgery patients, a new contact lens for irregular corneas, the Rose K2 XL oblate, has been unveiled by Menicon.

Matthews Eyecare has appointed Michael Cochrane as its new chief executive, replacing owner Phil Matthews, who will step down to focus on his strategic governance role on the company’s board.

A new survey by the Australia and New Zealand Child Myopia Working Group found 28% of New Zealand’s under-18s have never visited an optometrist for an eye check – a figure unchanged since a similar 2018 survey.

The Optometrists and Dispensing Opticians Board’s (ODOB) practitioner portals and public website have fallen victim to a cyber-attack, preventing access to many of the Board’s core systems. The attack

Aldeyra has announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ocular reproxalap, an investigational new drug candidate for the treatment